Liposomal LPT chewable tabs (lipotabs) provide a safe and more efficient way for the body to absorb nutrients, peptides and other targeted therapeutic compounds. LPTs do not have stability problems that plague the liposomal industry – LPTs are proven stable.
The name “liposome” is derived from two Greek words: “Lipos” meaning fat, and “Soma” meaning body. Liposomal delivery systems were first developed in the early 1960s and is part of what scientists call “nanotherapy” – making compounds smaller so they go from GUT to fitting into the cells more efficiently to cause a desired response. The first FDA approved liposomal drugs was the anti-cancer drug Doxil/doxorubicin in 1995. Currently, liposomes are successfully used in all types of drug delivery methods, and their applications in helping to treat complex biomedical issues is also progressively increasing.
Liposomes are lipid-based bilayer vesicles that can encapsulate, deliver, and release low-soluble drugs, supplements (herbs, vitamins/minerals, nutrients), peptides and other small molecules to a specific target site in the body, thus increasing therapeutic outcomes.
In general, liposomes are touted as a major advantage over regular oral delivery systems. Some of their benefits over general oral delivery include:
HOWEVER, liquid liposomal products have inherent stability issues.
• Liquid liposomes are the most popular delivery method
Most liposomal product particle size on the market is 100-300nm, whereas LIPOTABs are 70nm in size on average, which increases their absorption and clinical effects.
• Technology invented 2018 by PHARMA scientist - patent-pending
• Lipotabs are thermodynamically stable
• The smaller the particle size, the greater bioavailability
• Non-toxic excipients *
• Tableted liposome “lipotab” much more effective dispersion than liquid liposomes
• LPT particles don’t “clump” like liquid liposomes
Lipotabs are safe, chewable, oral liposomal tablets manufactured using patented, small molecule technology to improve bioavailability and biological effects.
• Oral drug delivery without the need for water
• Ease of swallowing
• Some of the agent will be absorbed buccally, bypassing hepatic circulation and metabolism
• Further improved bioavailability